Prot# SP-1011-02:FLUTicasone in Eosinophilic esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects with Eosinophilic Esophagitis

Project: Research project

Project Details

StatusActive
Effective start/end date2/8/182/8/21

Funding

  • Quintiles, Inc. (Prot# SP-1011-02)
  • Adare Pharmaceuticals, Inc. (Prot# SP-1011-02)